A hierarchical frailty model for familial testicular germ-cell tumors

American Journal of Epidemiology

Volumn 179, Issue 4, 2014, Pages 499-506

  Valberg, Morten ^a   Grotmol, Tom ^b   Tretli, Steinar ^b   Veierød, Marit B ^b   Moger, Tron A ^b   Aalen, Odd O ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b NONE

Author keywords

cancer familial; frailty; hierarchical models; nonseminoma; seminoma; survival analysis; susceptibility; testicular germ cell tumors

Indexed keywords

CANCER; CORRELATION; HEALTH RISK; HIERARCHICAL SYSTEM; POISSON RATIO; RISK FACTOR; SURVIVAL; TUMOR;

ADOLESCENT; AGED; ARTICLE; CANCER RISK; FAMILIAL CANCER; FAMILY; FOLLOW UP; GERM CELL TUMOR; HUMAN; MALE; NORWAY; PARAMETERS; RISK ASSESSMENT; SEMINOMA; TESTIS NONSEMINOMA CANCER; VERY ELDERLY; CONFIDENCE INTERVAL; GENETIC PREDISPOSITION; GENETICS; NEOPLASM; POISSON DISTRIBUTION; PROPORTIONAL HAZARDS MODEL; RISK; STATISTICAL MODEL; SURVIVAL ANALYSIS; TESTIS TUMOR;

NORWAY;

CONFIDENCE INTERVALS; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MODELS, STATISTICAL; NEOPLASMS, GERM CELL AND EMBRYONAL; POISSON DISTRIBUTION; PROPORTIONAL HAZARDS MODELS; RISK; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS;

EID: 84893321437     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwt267     Document Type: Article

References (51)

1. Cancer Registry of Norway. Cancer in Norway 2011-Cancer Incidence, Mortality, Survival and Prevalence in Norway. Oslo, Norway: Cancer Registry of Norway; 2013.
2. Huyghe E, Matsuda T, Thonneau P. Increasing incidence of testicular cancer worldwide: a review. J Urol. 2003;170(1): 5-11.
3. Bray F, Richiardi L, Ekbom A, et al. Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer. 2006;118(12):3099-3111.
4. Richiardi L, Tamimi R, Adami H-O. Testicular cancer. In: Adami H-O, Hunter D, Trichopoulos D, eds. Textbook of Cancer Epidemiology. New York, NY: Oxford University Press; 2008:555-572.
5. FormanD, Oliver RT, Brett AR, et al. Familial testicular cancer: a report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis. Br J Cancer. 1992;65(2):255-262.
6. Westergaard T, Olsen JH, Frisch M, et al. Cancer risk in fathers and brothers of testicular cancer patients in Denmark: a population-based study. Int J Cancer. 1996;66(5):627-631.
7. Heimdal K, Olsson H, Tretli S, et al. Familial testicular cancer in Norway and southern Sweden. Br J Cancer. 1996;73(7): 964-969.
8. Dong C, Lonnstedt I, Hemminki K. Familial testicular cancer and second primary cancers in testicular cancer patients by histological type. Eur J Cancer. 2001;37(15):1878-1885.
9. Bromen K, Stang A, Baumgardt-Elms C, et al. Testicular, other genital, and breast cancers in first-degree relatives of testicular cancer patients and controls. Cancer Epidemiol Biomarkers Prev. 2004;13(8):1316-1324.
10. Hemminki K, Li X. Familial risk in testicular cancer as a clue to a heritable and environmental aetiology. Br J Cancer. 2004; 90(9):1765-1770.
11. Nordsborg RB, Meliker JR, Wohlfahrt J, et al. Cancer in first-degree relatives and risk of testicular cancer in Denmark. Int J Cancer. 2011;129(10):2485-2491.
12. Swerdlow AJ, De Stavola BL, Swanwick MA, et al. Risks of breast and testicular cancers in young adult twins in England andWales: evidence on prenatal and genetic aetiology. Lancet. 1997;350(9093):1723-1728.
13. Kanetsky PA, Mitra N, Vardhanabhuti S, et al. Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nat Genet. 2009;41(7):811-815.
14. Rapley EA, Turnbull C, Al Olama AA, et al. A genome-wide association study of testicular germ cell tumor. Nat Genet. 2009;41(7):807-810.
15. Turnbull C, Rapley EA, Seal S, et al. Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. Nat Genet. 2010;42(7):604-607.
16. Chung CC, Kanetsky PA, Wang Z, et al. Meta-analysis identifies four new loci associated with testicular germ cell tumor. Nat Genet. 2013;45(6):680-685.
17. Ruark E, Seal S, McDonald H, et al. Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14. Nat Genet. 2013;45(6):686-689.
18. Hemminki K, Tretli S, Sundquist J, et al. Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway. Lancet Oncol. 2009;10(5):481-488.
19. Hemminki K, Vaittinen P, Dong C, et al. Sibling risks in cancer: clues to recessive or X-linked genes? Br J Cancer. 2001;84(3): 388-391.
20. Aalen OO, Tretli S. Analyzing incidence of testis cancer by means of a frailty model. Cancer Causes Control. 1999;10(4): 285-292.
21. Moger TA, Aalen OO, Halvorsen TO, et al. Frailty modelling of testicular cancer incidence using Scandinavian data. Biostatistics. 2004;5(1):1-14.
22. Moger TA, Aalen OO, Heimdal K, et al. Analysis of testicular cancer data using a frailty model with familial dependence. Stat Med. 2004;23(4):617-632.
23. Moger TA, Haugen M, Yip BH, et al. A hierarchical frailty model applied to two-generation melanoma data. Lifetime Data Anal. 2011;17(3):445-460.
24. Moger TA, Aalen OO. Regression models for infant mortality data in Norwegian siblings, using a compound Poisson frailty distribution with random scale. Biostatistics. 2008;9(3):577-591.
25. Moger TA, Aalen OO. A distribution for multivariate frailty based on the compound Poisson distribution with random scale. Lifetime Data Anal. 2005;11(1):41-59.
26. Agarwal PK, Palmer JS. Testicular and paratesticular neoplasms in prepubertal males. J Urol. 2006;176(3):875-881.
27. Hougaard P. Analysis of Multivariate Survival Data. New York, NY: Springer-Verlag New York; 2000.
28. Duchateau L, Janssen P. The Frailty Model. New York, NY: Springer Publishing Company; 2008.
29. Aalen OO, Borgan Ø, Gjessing HK. Survival and Event History Analysis: A Process Point of View. New York, NY: Springer Publishing Company; 2008.
30. Wienke A. Frailty Models in Survival Analysis. Boca Raton, FL: CRC Press; 2011.
31. Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer. 1954;8(1): 1-12.
32. Haugen M, Bray F, Grotmol T, et al. Frailty modeling of bimodal age-incidence curves of nasopharyngeal carcinoma in low-risk populations. Biostatistics. 2009;10(3):501-514.
33. Il'Yasova D, Siamakpour-Reihani S, Akushevich I, et al. What can we learn from the age- and race/ethnicity-specific rates of inflammatory breast carcinoma? Breast Cancer Res Treat. 2011;130(2):691-697.
34. Valberg M, Grotmol T, Tretli S, et al. Frailty modeling of age-incidence curves of osteosarcoma and Ewing sarcoma among individuals younger than 40 years. Stat Med. 2012; 31(28):3731-3747.
35. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2012.
36. Yu H. Rmpi: Interface (Wrapper) to MPI (Message-Passing Interface). (R package, version 0.6-1). Vienna, Austria: R Foundation for Statistical Computing; 2012.
37. Research Computing Services Group, IT Department, University of Oslo. Abel Cluster [supercomputer]. Oslo, Norway: University of Oslo and Norwegian Meta-Center for High Performance Computing; 2013.
38. Hemminki K, Eng C, Chen B. Familial risks for nonmedullary thyroid cancer. J Clin Endocrinol Metab. 2005;90(10): 5747-5753.
39. Zoller B, Ji J, Sundquist J, et al. Family history and risk of hospital treatment for varicose veins in Sweden. Br J Surg. 2012;99(7):948-953.
40. Fallah M, Pukkala E, Tryggvadottir L, et al. Risk of thyroid cancer in first-degree relatives of patients with non-medullary thyroid cancer by histology type and age at diagnosis: a joint study from five Nordic countries. J Med Genet. 2013;50(6): 373-382.
41. Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet. 2001;358(9291):1389-1399.
42. Bevier M, Sundquist K, Hemminki K. Risk of breast cancer in families of multiple affected women and men. Breast Cancer Res Treat. 2012;132(2):723-728.
43. Czene K, Lichtenstein P, Hemminki K. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int J Cancer. 2002;99(2): 260-266.
44. Skotheim RI, Lothe RA. The testicular germ cell tumour genome. APMIS. 2003;111(1):136-150.
45. Wanderås EH, Tretli S, Fosså SD. Trends in incidence of testicular cancer in Norway 1955-1992. Eur J Cancer. 1995; 31A(12):2044-2048.
46. Nielsen M, Andersson C, Gerds TA, et al. Familial clustering of myocardial infarction in first-degree relatives: a nationwide study. Eur Heart J. 2013;34(16):1198-1203.
47. Yashin AI, Vaupel JW, Iachine IA. Correlated individual frailty: an advantageous approach to survival analysis of bivariate data. Math Popul Stud. 1995;5(2): 145-159.
48. Korsgaard IR, Andersen AH. The additive genetic gamma frailty model. Scand J Stat. 1998;25(2):225-269.
49. Petersen JH. An additive frailty model for correlated life times. Biometrics. 1998;54(2):646-661.
50. Jonker MA, Boomsma DI. A frailty model for (interval) censored family survival data, applied to the age at onset of non-physical problems. Lifetime Data Anal. 2010;16(3): 299-315.
51. Moger TA, Pawitan Y, Borgan Ø. Case-cohort methods for survival data on families from routine registers. Stat Med. 2008; 27(7):1062-1074.